• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,346.17 -303.67
( -0.41%)
Global Indices
Nasdaq
51,336.08 236.20
(0.46%)
Dow Jones
7,632.10 11.14
(0.15%)
Hang Seng
68,675.29 1,941.05
(2.91%)
Nikkei 225
10,376.42 37.47
(0.36%)
Forex
USD-INR
95.08 0.33
(0.35%)
EUR-INR
110.66 0.19
(0.17%)
GBP-INR
127.93 0.48
(0.38%)
JPY-INR
0.60 0.00
(0.18%)

EQUITY - MARKET SCREENER

Gold Rock Investments Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
501111
INE598F01014
1735.0632911
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0.17
0.96
EPS(TTM)
Face Value()
Div & Yield %
69.64
10
0
 

kddl ltd
Biogen Pharmachem Industries reports standalone net loss of Rs 0.36 crore in the March 2026 quarter
May 15,2026
Net loss of Biogen Pharmachem Industries reported to Rs 0.36 crore in the quarter ended March 2026 as against net profit of Rs 1.18 crore during the previous quarter ended March 2025. There were no Sales reported in the quarter ended March 2026 and during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.86 crore in the year ended March 2026 as against net loss of Rs 0.29 crore during the previous year ended March 2025. There were no Sales reported in the year ended March 2026 and during the previous year ended March 2025.